Allogenic stem cell transplantation

3 trials 3 recruiting MedDRA PT
3 Registered trials
3 Recruiting
3 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 4
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase III: 1 Phase II: 1 Phase I (First in Human): 2

Filter these 3 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 3 trials

Phase III

1 trial
  • Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias Academic
    IMP not specified
    2024-520336-14-00 1 country n=156
    Pending

Phase II

1 trial
  • Maat Pharma Commercial
    ALLOGENEIC FAECAL MICROBIOTA, POOLED
    2022-501831-18-00 5 countries 2023 n=374
    Recruiting

Phase I (First in Human)

2 trials
  • Smart Immune Commercial
    ALLOGENEIC T-CELL PRECURSORS, MOBILIZED PERIPHERAL BLOOD-DERIVED, EX VIVO CULTURED
    2024-517953-28-00 2 countries 2023 n=39 Orphan
    Recruiting
  • Smart Immune Academic
    ALLOGENEIC T-CELL PRECURSORS, MOBILIZED PERIPHERAL BLOOD-DERIVED, EX VIVO CULTURED
    2024-517953-28-00 2 countries 2023 n=39 Orphan
    Recruiting
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Smart Immune Commercial 2 Phase I (First in Human) 2
Maat Pharma Commercial 1 Phase II 1
Fundacion Para La Investigacion Y La Innovacion Biosanitaria Del Principado De Asturias Academic 1 Phase III 0
New trials by year
2023
3
← All indication landscapes